ArticleFrontiers in pharmacology2026
A comparative study on the efficacy and safety of biosimilar (Rimmyrah) and reference ranibizumab in patients with diabetic macular edema.
Gaixia Zhai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.